OrbiMed Revenue and Competitors
Estimated Revenue & Valuation
- OrbiMed's estimated annual revenue is currently $35.3M per year.
- OrbiMed received $431.5M in venture funding in June 2017.
- OrbiMed's estimated revenue per employee is $193,750
Employee Data
- OrbiMed has 182 Employees.
- OrbiMed grew their employee count by 3% last year.
OrbiMed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Private Equity VP | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | VP | Reveal Email/Phone |
7 | VP | Reveal Email/Phone |
8 | VP, Investor Relations/Marketing | Reveal Email/Phone |
9 | Controller | Reveal Email/Phone |
10 | General Counsel | Reveal Email/Phone |
OrbiMed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is OrbiMed?
From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.
keywords:Biotechnology,Finance,Healthcare,Medical Diagnostics,Pharmaceuticals
N/A
Total Funding
182
Number of Employees
$35.3M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OrbiMed News
Sionna Therapeutics, a Sanofi Genzyme spinout, announced its launch with $111 million in Series B financing led by OrbiMed.
Backed by OrbiMed, Sionna hit the ground with a pipeline of first-in-class small molecules designed to fully restore the function of the...
Representative image. Healthcare focused US private equity fund Orbimed and UK's development finance institution CDC Group Plc are looking to...
₹225 cr fundraise from OrbiMed Asia Part" data-reg="LifeCell International announces ₹225 cr fundraise from OrbiMed Asia Part">LifeCell International announces ₹225 cr fundraise from OrbiMed Asia Part Premium LifeCell seeks to further leverage its technological expertise, strong brand position, ...
Premium OrbiMed, a US-based life sciences investment firm, has closed its fourth Asia-focused healthcare fund after garnering $800 million in commitments, surpassing its $750 million target. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Lo ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $52.8M | 182 | -9% | $36M |
#2 | $29.3M | 182 | -10% | $198.1M |
#3 | $50.1M | 182 | 8% | N/A |
#4 | $29M | 182 | N/A | N/A |
#5 | $52.8M | 182 | 8% | $8M |
OrbiMed Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2006-04-28 | $500.0M | Undisclosed | Article | |
| 2013-11-04 | $735.0M | Undisclosed | General Partner | Article |
| 2014-09-11 | $325.0M | Undisclosed | Article | |
| 2016-05-24 | $307.0M | Undisclosed | OrbiMed Israel Partners II, LP | Article |
| 2017-03-01 | $450.0M | Third Fund | Article | |
| 2017-06-30 | $431.5M | Third | Article |